DocShifter NV - Eedverbondkaai 242/003 B-9000 Gent Belgium - hello@docshifter.com
Search
Close this search box.

DocShifter helps large US biotech company streamline submissions by generating 30,000 compliant, submission-ready PDF's every month

Helping solve compliant regulatory content challenges

employees
1
documents / month
1
annual revenue
1 $
marketed products in the USA
More than 1

Challenges with previous rendering solution

One of the largest biotechnology companies in the US has selected DocShifter to speed up and automate submission content preparation.

This company was previously using another software to render all regulatory content; consisting of Word, PDF, Excel, TXT, RTF and image files to compliant PDF documents.

Due to many rendering-related (task failures, content processing problems) and other challenges (costs related to Office & Adobe tools), they made the switch to DocShifter.

The DocShifter impact

From 37 conversion servers to 14 DocShifter servers on-premise for the same content
37 servers
Faster Conversion for regulatory and other corporate content
1 x
Implemented and validated in 3 months.
1 months

Efficiency gains in regulatory
through automation

Quality

"During our initial tests, equal or higher quality results compared to previous solution. Higher and more reliable quality results were confirmed."

Cost

"The overall cost to maintain the legacy solution was very high due to the larger number of servers needed for the load and the multiple additional licensing needed to support those applications (OS, Office, Adobe, etc.)."

Risk

"While testing DocShifter, it was clear that there would be less system downtime and server issues than with legacy solutions. The higher quality output also reduces our risk of non-compliance."

"We use DocShifter to prepare compliant, submission-ready PDF renditions for all regulatory content.

The product is reliable, extremely fast and produces output that is compliant with multiple Health Authorities."
Regulatory Information Systems Manager
Large US biotech company